BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 37884534)

  • 1. FHL1 promotes chikungunya and o'nyong-nyong virus infection and pathogenesis with implications for alphavirus vaccine design.
    Ng WH; Liu X; Ling ZL; Santos CNO; Magalhães LS; Kueh AJ; Herold MJ; Taylor A; Freitas JR; Koit S; Wang S; Lloyd AR; Teixeira MM; Merits A; Almeida RP; King NJC; Mahalingam S
    Nat Commun; 2023 Oct; 14(1):6605. PubMed ID: 37884534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FHL1 is a major host factor for chikungunya virus infection.
    Meertens L; Hafirassou ML; Couderc T; Bonnet-Madin L; Kril V; Kümmerer BM; Labeau A; Brugier A; Simon-Loriere E; Burlaud-Gaillard J; Doyen C; Pezzi L; Goupil T; Rafasse S; Vidalain PO; Bertrand-Legout A; Gueneau L; Juntas-Morales R; Ben Yaou R; Bonne G; de Lamballerie X; Benkirane M; Roingeard P; Delaugerre C; Lecuit M; Amara A
    Nature; 2019 Oct; 574(7777):259-263. PubMed ID: 31554973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and Functional Characterization of Host FHL1 Protein Interaction with Hypervariable Domain of Chikungunya Virus nsP3 Protein.
    Lukash T; Agback T; Dominguez F; Shiliaev N; Meshram C; Frolova EI; Agback P; Frolov I
    J Virol; 2020 Dec; 95(1):. PubMed ID: 33055253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of MXRA8 in Ross River Virus Disease Pathogenesis.
    Ng WH; Ling ZL; Kueh AJ; Herold MJ; West NP; King NJC; Mahalingam S; Liu X
    mBio; 2023 Apr; 14(2):e0058823. PubMed ID: 37036079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation Sites in the Hypervariable Domain in Chikungunya Virus nsP3 Are Crucial for Viral Replication.
    Teppor M; Žusinaite E; Merits A
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33568506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GloPID-R report on chikungunya, o'nyong-nyong and Mayaro virus, part 2: Epidemiological distribution of o'nyong-nyong virus.
    Pezzi L; LaBeaud AD; Reusken CB; Drexler JF; Vasilakis N; Diallo M; Simon F; Jaenisch T; Gallian P; Sall A; Failloux AB; Weaver SC; de Lamballerie X;
    Antiviral Res; 2019 Dec; 172():104611. PubMed ID: 31545982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GloPID-R report on chikungunya, o'nyong-nyong and Mayaro virus, part 5: Entomological aspects.
    Pezzi L; Diallo M; Rosa-Freitas MG; Vega-Rua A; Ng LFP; Boyer S; Drexler JF; Vasilakis N; Lourenco-de-Oliveira R; Weaver SC; Kohl A; de Lamballerie X; Failloux AB;
    Antiviral Res; 2020 Feb; 174():104670. PubMed ID: 31812638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GloPID-R report on Chikungunya, O'nyong-nyong and Mayaro virus, part I: Biological diagnostics.
    Pezzi L; Reusken CB; Weaver SC; Drexler JF; Busch M; LaBeaud AD; Diamond MS; Vasilakis N; Drebot MA; Siqueira AM; Ribeiro GS; Kohl A; Lecuit M; Ng LFP; Gallian P; de Lamballerie X;
    Antiviral Res; 2019 Jun; 166():66-81. PubMed ID: 30905821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High rates of o'nyong nyong and Chikungunya virus transmission in coastal Kenya.
    LaBeaud AD; Banda T; Brichard J; Muchiri EM; Mungai PL; Mutuku FM; Borland E; Gildengorin G; Pfeil S; Teng CY; Long K; Heise M; Powers AM; Kitron U; King CH
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003436. PubMed ID: 25658762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the Mxra8 Receptor Promotes Alphavirus Infection and Pathogenesis in Mice and Drosophila.
    Zhang R; Earnest JT; Kim AS; Winkler ES; Desai P; Adams LJ; Hu G; Bullock C; Gold B; Cherry S; Diamond MS
    Cell Rep; 2019 Sep; 28(10):2647-2658.e5. PubMed ID: 31484075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of Chikungunya and O'nyong-Nyong Virus Specificity for Infection of
    Cottis S; Blisnick AA; Failloux AB; Vernick KD
    Viruses; 2023 Feb; 15(3):. PubMed ID: 36992298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FHL1 is a key player of chikungunya virus tropism and pathogenesis.
    Meertens L; Hafirassou ML; Couderc T; Bonnet-Madin L; Kril V; Kümmerer BM; Labeau A; Brugier A; Simon-Loriere E; Burlaud-Gaillard J; Doyen C; Pezzi L; Goupil T; Rafasse S; Vidalain PO; Legout AB; Gueneau L; Juntas-Morales R; Yaou RB; Bonne G; de Lamballerie X; Benkirane M; Roingeard P; Delaugerre C; Lecuit M; Amara A
    C R Biol; 2021 Apr; 343(4):79-89. PubMed ID: 33988325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arthritogenic Alphavirus Vaccines: Serogrouping Versus Cross-Protection in Mouse Models.
    Nguyen W; Nakayama E; Yan K; Tang B; Le TT; Liu L; Cooper TH; Hayball JD; Faddy HM; Warrilow D; Allcock RJN; Hobson-Peters J; Hall RA; Rawle DJ; Lutzky VP; Young P; Oliveira NM; Hartel G; Howley PM; Prow NA; Suhrbier A
    Vaccines (Basel); 2020 May; 8(2):. PubMed ID: 32380760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Linked Glycans Shape Skin Immune Responses during Arthritis and Myositis after Intradermal Infection with Ross River Virus.
    Tharmarajah K; Everest-Dass A; Vider J; Liu X; Freitas JR; Mostafavi H; Bettadapura J; von Itzstein M; West NP; Taylor A; Mahalingam S; Zaid A
    J Virol; 2022 Sep; 96(17):e0099922. PubMed ID: 36000846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mxra8 is a receptor for multiple arthritogenic alphaviruses.
    Zhang R; Kim AS; Fox JM; Nair S; Basore K; Klimstra WB; Rimkunas R; Fong RH; Lin H; Poddar S; Crowe JE; Doranz BJ; Fremont DH; Diamond MS
    Nature; 2018 May; 557(7706):570-574. PubMed ID: 29769725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model-based assessment of Chikungunya and O'nyong-nyong virus circulation in Mali in a serological cross-reactivity context.
    Hozé N; Diarra I; Sangaré AK; Pastorino B; Pezzi L; Kouriba B; Sagara I; Dabo A; Djimdé A; Thera MA; Doumbo OK; de Lamballerie X; Cauchemez S
    Nat Commun; 2021 Nov; 12(1):6735. PubMed ID: 34795213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species-specific MARCO-alphavirus interactions dictate chikungunya virus viremia.
    Li FS; Carpentier KS; Hawman DW; Lucas CJ; Ander SE; Feldmann H; Morrison TE
    Cell Rep; 2023 May; 42(5):112418. PubMed ID: 37083332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chikungunya Virus Exposure Partially Cross-Protects against Mayaro Virus Infection in Mice.
    Fumagalli MJ; de Souza WM; de Castro-Jorge LA; de Carvalho RVH; Castro ÍA; de Almeida LGN; Consonni SR; Zamboni DS; Figueiredo LTM
    J Virol; 2021 Nov; 95(23):e0112221. PubMed ID: 34549980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Humoral Immune Responses in Chikungunya Virus (CHIKV)-Infected Patients and Individuals Vaccinated With a Candidate CHIKV Vaccine.
    Henss L; Yue C; Von Rhein C; Tschismarov R; Lewis-Ximenez LL; Dölle A; Baylis SA; Schnierle BS
    J Infect Dis; 2020 Apr; 221(10):1713-1723. PubMed ID: 31828322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of Alphaviruses (
    Abdoullah B; Durand GA; Basco LK; El Bara A; Bollahi MA; Bosio L; Geulen M; Briolant S; Boukhary AOMS
    Viruses; 2023 Jul; 15(7):. PubMed ID: 37515274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.